Delivery Order SPE2DB20D1109-SPE2DB25FN97H
Award Date
4/29/25
Potential Completion Date
5/20/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $6,658.73 firm-fixed-price contract provides for the delivery of ANDEXXA 200 MG vials, a specialized medication. The contract has a completion date of November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,888.85, is for the delivery of 4566586927 ANDEXXA 200MG VIALS 4S. This is a Firm Fixed Price Delivery Order contract with a performance period through December 4, 2024. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product, with a ceiling value of $6,931.53 and a period of performance through May 12, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $79,161.66 firm fixed-price delivery order is for the supply of ANDEXXA 200 MG VIALS. The contract has an ultimate completion date of November 18, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,726.12 firm-fixed-price contract is for the supply of 4,567,955,833 units of the medication ANDEXXA 200 MG VIALS. The award has an ultimate completion date of May 8, 2025 and was made on April 17, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support...
This federal contract award, with a ceiling value of $26,388.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a Delivery Order for the pharmaceutical product ANDEXXA 200 MG VIALS, with a completion date of July 19, 2022. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds two...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,387.22 firm-fixed-price delivery order is for the supply of ANDEXXA 200 MG VIALS, a specialized medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the...
This federal contract award, valued at $14,801.16, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distribution company. The contract is for the supply of ANDEXXA 200 MG VIALS, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen Drug Corporation and DLA, valued at up to $999,999,999.00 and running through December 31, 2025....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation. The contract, valued at $7,570.17, is for the supply of ANDEXXA 200 MG VIALS, a specialty pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) with a total potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ANDEXXA 200 MG VIALS, a medical product, with a ceiling value of $6,931.53 and a period of performance through April 11, 2025. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...